Education
About Us
Working with TipRanks
Follow Us
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
Total Valuation
Phio Pharmaceuticals has a market cap or net worth of $7.88M. The enterprise value is -$2.26M.
Market Cap$7.88M
Enterprise Value-$2.26M
Share Statistics
Phio Pharmaceuticals has 4.78M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4.78M
Owened by Insiders1.04%
Owened by Instutions0.86%
Financial Efficiency
Phio Pharmaceuticals’s return on equity (ROE) is -1.40 and return on invested capital (ROIC) is -139.39%.
Return on Equity (ROE)-140.05%
Return on Assets (ROA)-115.61%
Return on Invested Capital (ROIC)-139.39%
Return on Capital Employed (ROCE)-140.03%
Revenue Per Employee$3,750
Profits Per Employee-$927,375
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Phio Pharmaceuticals is -0.15. Phio Pharmaceuticals’s PEG ratio is <0.01.
PE Ratio-0.15
PS Ratio0.00
PB Ratio0.20
Price to Fair Value0.20
Price to FCF-0.15
Price to Operating Cash Flow-0.15
PEG Ratio<0.01
Income Statement
In the last 12 months, Phio Pharmaceuticals had revenue of $30.00K and earned -$7.42M in profits. Earnings per share was -$13.96.
Revenue$30.00K
Gross Profit-$48.00K
Operating Income-$7.49M
Pretax Income-$7.42M
Net Income-$7.42M
EBITDA-7.29M
Earnings Per Share (EPS)-13.96
Cash Flow
In the last 12 months, operating cash flow was -$7.52M and capital expenditures $0.00, giving a free cash flow of -$7.52M billion.
Operating Cash Flow-$7.52M
Free Cash Flow-$7.52M
Free Cash Flow per Share-$1.57
Dividends & Yields
Phio Pharmaceuticals pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-680.62%
Earnings Yield-685.17%
Stock Price Statistics
Beta2.79
52-Week Price Change-70.95%
50-Day Moving Average1.49
200-Day Moving Average2.72
Relative Strength Index (RSI)39.67
Average Volume (3m)5.34M
Important Dates
Phio Pharmaceuticals upcoming earnings date is May 8, 2025, Before Open.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Phio Pharmaceuticals as a current ratio of 5.71, with Debt / Equity ratio of <0.01
Current Ratio5.71
Quick Ratio5.71
Debt to Market Cap0.00
Net Debt to EBITDA0.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Phio Pharmaceuticals has paid $41.72K in taxes.
Income Tax$41.72K
Effective Tax Rate0.00%
Enterprise Valuation
Phio Pharmaceuticals EV to EBITDA ratio is 0.65, with an EV/FCF ratio of 0.64.
EV to Sales0.00
EV to EBITDA0.65
EV to Free Cash Flow0.64
EV to Operating Cash Flow0.64
Balance Sheet
Phio Pharmaceuticals has $5.39M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$5.39M billion.
Cash & Marketable Securities$5.39M
Total Debt$0.00
Net Cash-$5.39M
Net Cash Per Share-$1.13
Tangible Book Value Per Share$33.46
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Phio Pharmaceuticals is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.00
Price Target Upside129.89%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast81.71%